0
     

Report Added
Report already added
Cell Therapy Biomanufacturing: Global Markets

Cell Therapy Biomanufacturing: Global Markets

Report Scope:

This research report presents an in-depth analysis of the global cell therapy biomanufacturing market by product type, application and region. The report discusses the key inhibitors to the growth of cell therapy biomanufacturing. The report discusses the role of participants in the supply chain from manufacturers to researchers. The report analyzes key companies operating in the global cell therapy biomanufacturing market. In-depth patent analysis in the report will provide a look at the existing and coming technological trends.

In this report, the cell therapy biomanufacturing market is segmented by product type, application and region. Based on product type, the market is segmented into source of cells (T-cells, Dendritic cells, tumor cells and stem cells), and type of therapy (autologous cell therapies, allogeneic cell therapies). The market by application is categorized into cardiovascular diseases, bone repair, neurological disorders, skeletal muscle repair, cancer and others. The market by region is segmented into North America, Europe, Asia-Pacific and ROW.

Report Includes:

- 23 tables
- An overview of the global markets for cell therapy biomanufacturing
- Estimation of the market size and analyses of global market trends with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Assessment of market dynamics such as drivers, restraints, opportunities, and identification of growth inhibiting areas that affect the global market
- Detailed description of allogeneic (third party donor cells) and autologous (one's own body cells) forms of cell therapy and analysis of its advantages and limitations
- Information on clinical trials of cell therapies; insights into regulatory scenarios and initiatives by government organization
- Evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies; and a relevant patent analysis
- Company profiles of major players of the industry, including Bristol-Myers Squibb Co., Caladrius Biosciences Inc., Lonza Group Ltd., Merck KGaA and Novartis AG
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Market Estimates
Information Sources
Primary Research
Secondary Research
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Introduction
Chapter 3 Market and Technology Background
Introduction to Cell Therapy Biomanufacturing
What is Cell Therapy?
Stem Cell Transplantation
Autologous
Allogeneic
Syngeneic
Stem Cell Biomanufacturing and Classification
Based on Ability to Differentiate
Based on Source
Classification of Cell-Based Therapy Technology
Somatic Cell Technologies
Three-Dimensional Technologies
Cell Immortalization Technologies
Genome Editing Technologies
Cell Plasticity Technologies
Ex vivo Gene Modification of Cells Using Viral Vector Technologies
In vivo Gene Modification of Cells Using Viral Vector Technologies
Stem Cell Applications
Mechanism of Cell Therapy
Delivery Method of Cell-Based Therapy
Manufacturing Cell Therapy Models
Role of Contract Manufacturers
Ongoing Clinical Trials
Clinical Trial Network Focused on Stem Cell Treatments
Chapter 4 Market Trends and Challenges
Challenges
Drivers
Restraints
Opportunity
Chapter 5 Market Breakdown by Product Type
Type of Therapy
Source of Cells
Rise in the Demand for Chimeric Antigen Receptor (CAR) T Cell Therapy
Chapter 6 Market Breakdown by Application
Cardiovascular Disease
Microparticles Cell Imitation
Bone Repair
Neurological Disorders
Spinal Cord Injury
Stroke
Parkinson’s Disease
Amyotrophic Lateral Sclerosis
Multiple Sclerosis
Cerebral Palsy
Alzheimer's Disease
Vision Restoration
Vertebral Repair
Batten's Disease
Skeletal Muscle Repair
Intrinsic Healing Mechanisms
Cell Therapy Mechanism
Cancer
Other Diseases
Chapter 7 Market Breakdown by Region
Market Overview
North America
U.S.
Canada
Mexico
Europe
Cardiovascular Diseases in Europe
Contributing Factors for Cardiovascular Diseases (CVD)
Germany
U.K.
France
Asia-Pacific
China
India
Japan
Rest of APAC
Rest of the World
South America
Middle East and Africa
Chapter 8 Regulatory Structure
FDA Approvals
Cell Therapy for CBER Regulations
Federal Regulation codes
Collection of Cells
Code of Regulation
Legislation Governing Use of Stem Cell Treatments
EU Determination of Regulatory Status
Regulatory Scenario in India
Chapter 9 Company Profiles
BONE THERAPEUTICS SA
BRISTOL-MYERS SQUIBB CO.
CALADRIUS BIOSCIENCES INC.
CELL THERAPIES PTY LTD.
CELLULAR BIOMEDICINE GROUP INC.
IOVANCE BIOTHERAPEUTICS INC.
LONZA GROUP LTD.
MERCK KGAA
NEUROGENERATION INC.
NOVARTIS AG
REGEN BIOPHARMA INC.
REGENEUS LTD.
Chapter 10 Appendix: References
Sources

Report Title: Cell Therapy Biomanufacturing: Global Markets


Your Details
Valid Invalid number

Related Report

Saudi Arabia Ophthalmic Equipment Market, By Product (Vision Care Products, Ophthalmology Surgical Devices, Diagnostic & Monitoring Devices, Others), By Application (Glaucoma, Amblyopia, Cataract, Retinal Detachment, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Ophthalmic Equipment Market, By Product (Vision Care Products, Ophthalmology Surgical Devices, Diagnostic & Monitoring Devices, Others), By Application (Glaucoma, Amblyopia, Cataract, Retinal Detachment, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Medical Devices Market, By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Company, By Region, Forecast & Opportunities, 2027

Saudi Arabia Medical Devices Market, By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Company, By Region, Forecast & Opportunities, 2027


Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-to-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems and Open MRI Systems), By Source (Domestic v/s Import), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Magnetic Resonance Imaging Market, By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-to-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above)), By Type (Fixed, Mobile), By Architecture (Closed MRI Systems and Open MRI Systems), By Source (Domestic v/s Import), By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others), By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Human Insulin Market, By Indication (Type I Diabetes, Type II Diabetes), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2027


Saudi Arabia Hospital Market, By Ownership (Public v/s Private), By Type (General, Specialty, Multi- Speciality), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds), By Region, Company Forecast & Opportunities, 2027

Saudi Arabia Hospital Market, By Ownership (Public v/s Private), By Type (General, Specialty, Multi- Speciality), By Type of Services (In-Patient Services v/s Out-Patient Services), By Bed Capacity (Up to 100 beds, 100-500 beds, Above 500 beds), By Region, Company Forecast & Opportunities, 2027


Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027

Saudi Arabia Eye Drops Market, By Type (Prescription v/s Over-The-Counter), By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others), By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others), By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals & Clinics, Homecare, Others), By Region, Competition Forecast & Opportunities, 2027


SELECT A FORMAT

ADD TO CART BUY NOW